28 June 2017 - Deborah Wilkes
Archived
The Polish government's decision to reverse-switch emergency contraceptives to prescription-only medicines is not a wise decision, according to the Association of the European Self-Medication Industry (AESGP). The move will affect HRA Pharma's EllaOne (ulipristal acetate), which was switched to non-prescription status in 2015 through the European Union's centralised procedure.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.